InvestSMART

ImExHS Limited (ASX:IME)

ALERT: Price-sensitive ASX Announcement for IME
Current share price for IME : $0.310 -0.08 (-20.51%)+
Announcement
Release
30 Apr 2026 9:45AM
Price at Release
$0.390
Full Release
download
Summary
IMEXHS Limited reported strong performance in Q1 FY26, with revenues increasing by 13% from the previous year, and an annualised recurring revenue of $34.8 million. The company is advancing its AI-native platform strategy with the development of five proprietary AI agents to streamline radiology workflows. Significant contracts were secured in Colombia and Peru, contributing to the growth in new software deals. IMEXHS ended the quarter with cash reserves of $2.5 million, managing to navigate political risks in Colombia that affected client cash flows. The company has improved its sales and pipeline management processes and expects to exceed previous year's EBITDA by the end of FY26.
Key Points
  • Q1 FY26 revenue of $7.9 million, up 13% from the previous corresponding period.
  • Annualised Recurring Revenue (ARR) of $34.8 million, up 11% vs pcp.
  • Development of five proprietary AI agents for radiology workflow.
  • Two AI agents are live, with others in testing or development.
  • IMEXHS secured significant contracts in Colombia and Peru.
  • Revenue from software NARR of $427,000 across 14 deals in Q1 FY26.
  • Cash and cash equivalents of $2.5 million at the end of March 2026.
  • Implemented enhanced pipeline management and sales execution processes.
  • Political risks in Colombia affecting cash flow from clients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.